ORPH.L Share News (ORPH)
ORPH Share
ORPH Share
ORPH Share
ORPH Share
ORPH
ORPH Share
ORPH Broker
ORPH Directors
ORPH Financial
ORPH
ORPH Short
ORPH
(Sharecast News) - Contract research organisation Open Orphan said on Monday that its Venn Life Sciences subsidiary had signed a contract renewal with an unnamed "major global pharmaceutical client" worth £1.5m over a two-year period.
Read more
EXECUTIVE CHANGES: Halfords hires CFO; new Pendragon, Versarien chairs
Read more(Sharecast News) - Clinical research organisation Open Orphan announced on Monday that its subsidiary hVIVO has signed a £5.7m contract with a specialist biotechnology company developing therapeutics for respiratory viral infections, to test its antiviral product using the hVIVO Influenza human challenge study model.
Read moreTRADING UPDATES: Christie Group and Open Orphan swing to profit
Read moreUK earnings, trading statements calendar - next 7 days
Read moreTRADING UPDATES: Victoria growth continues; Renew to beat consensus
Read moreTRADING UPDATES: Marlowe buys Santia; Gaming Realms notes new launch
Read moreAIM WINNERS & LOSERS: Open Orphan rises on asthma study contract win
Read moreOpen Orphan shares lift on GBP8.1 million asthma study contract win
Read moreTRADING UPDATES: Netcall wins new deal; Sareum raises GBP1 million
Read moreAIM WINNERS & LOSERS: Restore rises as it rebuffs Marlowe approach
Read moreUK shareholder meetings calendar - next 7 days
Read moreIN BRIEF: Open Orphan study grows, spinoff worth GBP50 million at IPO
Read moreIN BRIEF: Open Orphan team invests GBP350,000 as spin-off set to debut
Read more(Sharecast News) - Pharmaceutical services company Open Orphan has secured a new contract win with an unnamed existing customer.
Read more